Plasma and cerebrospinal fluid pharmacokinetics of cytosine arabinoside in dogs
- 1 January 1991
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 29 (1), 13-18
- https://doi.org/10.1007/bf00686329
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C)Cancer, 1982
- Effects of high-dose cytarabineClinical Pharmacology & Therapeutics, 1982
- The pharmacokinetics of cytosine arabinoside in the plasma and cerebrospinal fluid during conventional and high-dose therapyMedical and Pediatric Oncology, 1982
- Use of cytosar in pediatric acute myelocytic leukemia and leukemic meningitisMedical and Pediatric Oncology, 1982
- Pharmacokinetics of cytosine arabinoside in patients with acute myeloid leukaemia.British Journal of Clinical Pharmacology, 1979
- Advances in the Treatment of Acute Myelogenous LeukemiaNew England Journal of Medicine, 1979
- Involvement of the central nervous system by non-Hodgkin's lymphoma.The southwest oncology group experienceCancer, 1979
- Pharmacokinetics of cytosine arabinoside in acute myeloid leukemiaClinical Pharmacology & Therapeutics, 1977
- Clinical pharmacology of l‐β‐D‐arabinofuranosyl cytosineClinical Pharmacology & Therapeutics, 1971
- Intrathecal Chemotherapy in Burkitt's LymphomaBMJ, 1971